Trial Profile
A Prospective Pilot Study to Investigate the Effectiveness of Quinagolide in the Improvement of Psychological Symptoms Associated with Hyperprolactinaemia.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs Quinagolide (Primary) ; Bromocriptine
- Indications Hyperprolactinaemia
- Focus Therapeutic Use
- 05 Sep 2019 Status changed from recruiting to discontinued.
- 23 Jun 2011 New trial record